Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHUKRA PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SHUKRA PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    SHUKRA PHARMA
Mar-23
TEVA PHARMA
Dec-13
SHUKRA PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs893,481-   
Low Rs113,024-   
Sales per share (Unadj.) Rs53.71,997.6-  
Earnings per share (Unadj.) Rs4.0124.8-  
Cash flow per share (Unadj.) Rs5.7286.3-  
Dividends per share (Unadj.) Rs0.50109.24-  
Avg Dividend yield %1.03.4 29.8%  
Book value per share (Unadj.) Rs23.12,219.0-  
Shares outstanding (eoy) m10.96848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.91.6 57.1%   
Avg P/E ratio x12.426.1 47.6%  
P/CF ratio (eoy) x8.811.4 77.1%  
Price / Book Value ratio x2.21.5 147.5%  
Dividend payout %12.487.5 14.2%   
Avg Mkt Cap Rs m5472,757,874 0.0%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m440-   
Avg. sales/employee Rs Th037,690.2-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,354.5-  
INCOME DATA
Net Sales Rs m5881,693,984 0.0%  
Other income Rs m120-   
Total revenues Rs m6001,693,984 0.0%   
Gross profit Rs m54463,899 0.0%  
Depreciation Rs m18136,926 0.0%   
Interest Rs m333,273 0.0%   
Profit before tax Rs m44293,700 0.0%   
Minority Interest Rs m01,334 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,798 -0.0%   
Tax Rs m0-3,586 -0.0%   
Profit after tax Rs m44105,822 0.0%  
Gross profit margin %9.127.4 33.3%  
Effective tax rate %0.8-1.2 -64.9%   
Net profit margin %7.56.2 119.9%  
BALANCE SHEET DATA
Current assets Rs m5311,144,111 0.0%   
Current liabilities Rs m425997,761 0.0%   
Net working cap to sales %18.08.6 207.9%  
Current ratio x1.21.1 108.9%  
Inventory Days Days091 0.0%  
Debtors Days Days1,87396 1,952.6%  
Net fixed assets Rs m219553,293 0.0%   
Share capital Rs m394,170 0.9%   
"Free" reserves Rs m2140-   
Net worth Rs m2531,881,695 0.0%   
Long term debt Rs m38866,172 0.0%   
Total assets Rs m7503,871,297 0.0%  
Interest coverage x16.89.8 171.0%   
Debt to equity ratio x0.10.5 32.4%  
Sales to assets ratio x0.80.4 179.4%   
Return on assets %6.33.6 174.0%  
Return on equity %17.45.6 309.7%  
Return on capital %16.24.9 329.5%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m32269,933 0.0%  
From Investments Rs m-44-95,648 0.0%  
From Financial Activity Rs m49-323,803 -0.0%  
Net Cashflow Rs m37-149,518 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.39 Rs / USD

Compare SHUKRA PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare SHUKRA PHARMA With: ELDER PHARMA  AUROBINDO PHARMA  VILIN BIO MED  CHEMO PHARMA  INNOVA CAPTAB LTD.  



Today's Market

Sensex Today Trades Higher | Nifty Nears 22,700 | Trent Jumps 6%, Tata Chemicals Drops 3% Sensex Today Trades Higher | Nifty Nears 22,700 | Trent Jumps 6%, Tata Chemicals Drops 3%(10:30 am)

Asian stocks inched higher on Tuesday as investors awaited a slew of economic data, corporate earnings and the U.S. Federal Reserve's policy meeting.